# Liminatus Pharma, Inc.: filings LIMN · Nasdaq · CIK 1971387 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/limn.md) · [Financials](/companies/limn/financials.md) · [Filings](/companies/limn/filings.md) · [Insiders](/companies/limn/insiders.md) ## Reports and events: 38 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 23, 3 14, CORRESP 13, UPLOAD 9, SCHEDULE 13G 6, 10-Q 5, S-4/A 5, 424B3 4, EFFECT 4, POS AM 3, S-1 3, 4 2, DRS 2, NT 10-Q 2, SCHEDULE 13D 2, 10-K 1, 424B4 1, 8-K12B 1, 8-K/A 1, D 1, DEF 14A 1, PRE 14A 1, S-1/A 1, S-4 1, SCHEDULE 13D/A 1, SCHEDULE 13G/A 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-29 | 05:15 ET | [8-K](/filings/0001104659-26-111665.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-111665 | | 2026-08-18 | 16:06 ET | [8-K](/filings/0001104659-26-098335.md) | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-098335 | | 2026-08-14 | 16:51 ET | [10-Q](/filings/0001104659-26-097304.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097304 | | 2026-08-04 | 16:30 ET | [8-K](/filings/0001104659-26-090423.md) | 5.07 Shareholder vote results | 0001104659-26-090423 | | 2026-07-30 | 21:49 ET | [8-K](/filings/0001104659-26-088380.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088380 | | 2026-07-24 | 16:51 ET | [8-K](/filings/0001104659-26-086674.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-086674 | | 2026-07-14 | 17:36 ET | [SCHEDULE 13D/A](/filings/0001104659-26-083585.md) | Ownership report, active investor, amended | 0001104659-26-083585 | | 2026-07-13 | 08:43 ET | [DEF 14A](/filings/0001104659-26-082905.md) | Proxy statement, period 2026-08-03 | 0001104659-26-082905 | | 2026-07-06 | 09:13 ET | [8-K](/filings/0001104659-26-080613.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-080613 | | 2026-06-24 | 21:28 ET | [S-1](/filings/0001104659-26-076958.md) | Registration statement | 0001104659-26-076958 | | 2026-06-03 | 17:14 ET | [8-K](/filings/0001104659-26-070173.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-070173 | | 2026-05-27 | 16:30 ET | [8-K](/filings/0001104659-26-066974.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-26-066974 | | 2026-05-20 | 17:00 ET | [8-K](/filings/0001104659-26-064585.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-064585 | | 2026-05-15 | 16:49 ET | [10-Q](/filings/0001104659-26-062734.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062734 | | 2026-03-31 | 17:28 ET | [10-K](/filings/0001104659-26-037933.md) | Annual report, period 2025-12-31 | 0001104659-26-037933 | | 2026-03-04 | 16:15 ET | [8-K](/filings/0001104659-26-023467.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-023467 | | 2026-02-18 | 17:13 ET | [8-K](/filings/0001104659-26-017134.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-017134 | | 2026-02-11 | 06:08 ET | [S-1](/filings/0001104659-26-012942.md) | Registration statement | 0001104659-26-012942 | | 2026-02-09 | 15:01 ET | [8-K](/filings/0001104659-26-012016.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-012016 | | 2026-01-26 | 16:31 ET | [8-K](/filings/0001104659-26-006619.md) | 3.01 Delisting notice | 0001104659-26-006619 | | 2025-11-25 | 17:26 ET | [8-K](/filings/0001104659-25-116049.md) | 3.01 Delisting notice | 0001104659-25-116049 | | 2025-11-14 | 21:01 ET | [10-Q](/filings/0001104659-25-111651.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111651 | | 2025-10-06 | 21:53 ET | [10-Q](/filings/0001104659-25-096872.md) | Quarterly report, period 2025-06-30 | 0001104659-25-096872 | | 2025-08-25 | 17:15 ET | [8-K](/filings/0001104659-25-082579.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-082579 | | 2025-08-14 | 16:06 ET | [8-K](/filings/0001104659-25-078577.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078577 | | 2025-07-28 | 21:59 ET | [S-1/A](/filings/0001410578-25-001518.md) | Registration statement, amended | 0001410578-25-001518 | | 2025-07-17 | 16:19 ET | [8-K](/filings/0001104659-25-068670.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001104659-25-068670 | | 2025-07-11 | 17:02 ET | [8-K](/filings/0001104659-25-067444.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-067444 | | 2025-07-03 | 11:40 ET | [8-K](/filings/0001104659-25-065663.md) | 8.01 Other events | 0001104659-25-065663 | | 2025-06-24 | 16:49 ET | [S-1](/filings/0001410578-25-001432.md) | Registration statement | 0001410578-25-001432 | | 2025-06-24 | 15:03 ET | [8-K](/filings/0001104659-25-062058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-062058 | | 2025-06-24 | 06:03 ET | [8-K](/filings/0001104659-25-061875.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061875 | | 2025-06-04 | 16:31 ET | [8-K](/filings/0001104659-25-056421.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-056421 | | 2025-06-02 | 21:45 ET | [10-Q](/filings/0001410578-25-001388.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001388 | | 2025-06-02 | 21:43 ET | [8-K/A](/filings/0001104659-25-055078.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-055078 | | 2025-05-08 | 16:21 ET | [SCHEDULE 13D](/filings/0001200876-25-000020.md) | Ownership report, active investor | 0001200876-25-000020 | | 2025-05-07 | 17:11 ET | [SCHEDULE 13D](/filings/0001104659-25-045628.md) | Ownership report, active investor | 0001104659-25-045628 | | 2025-05-06 | 17:20 ET | [8-K](/filings/0001104659-25-045127.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045127 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.